Sutro Biopharma (STRO) and Mersana Therapeutics (MRSN) gained Wednesday after ImmunoGen (IMGN) posted positive data for its ovarian cancer therapy.
https://seekingalpha.com/news/3964512-sutro-stock-mersana-stock-jump-immunogen-ovarian-cancer-data
Note: Only a member of this blog may post a comment.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.